Services on Demand
Journal
Article
Indicators
Cited by SciELO
Related links
Similars in SciELO
Share
Memorias del Instituto de Investigaciones en Ciencias de la Salud
On-line version ISSN 1812-9528
Abstract
ACOSTA-RECALDE, Patricia et al. Use of medicinal plants and phytotherapic compounds in patients with Diabetes Mellitus type 2. Mem. Inst. Investig. Cienc. Salud [online]. 2018, vol.16, n.2, pp.6-11. ISSN 1812-9528. https://doi.org/10.18004/mem.iics/1812-9528/2018.016(02)06-011.
A large number of plant species are used for medicinal purposes to treat different pathologies, including diabetes, which in 2015 presented the greatest economic burden in the countries of Latin America and the Caribbean. In turn, WHO considers the use of medicinal plants a more natural, more innocuous, effective therapy, of rational cost and affordable to the populations. Therefore, to establish the safe use it is necessary the correct identification. The objective of the study was to describe the medicinal plants and / or phytotherapic compounds used by patients with diabetes mellitus type 2. For this descriptive cross sectional study, 41 patients registered in the National Diabetes Program who attended regular consultation in January, 2015 were included. More than half of the sample reported use of some type of medicinal plants for the treatment of diabetes mellitus type 2. The medicinal plants mostly used mentioned by the patients were: Jaguareté po (Jungia floribunda Less.), Wormwood (Artemisia absinthium L.), Moringa (Moringa oleifera L.), and Insulin (Cissus verticillata (L.) Nicolson & CE Jarvis). The average number of plants consumed per patient was three. Through this type of studies, medicinal plants and phytotherapic compounds can be described, new information generated and thus promote a more rational use.
Keywords : medicinal plants; phytotherapic compounds; diabetes; Paraguay.